Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-Lactamases.
Cawez F, Mercuri PS, Morales-Yãnez FJ, Maalouf R, Vandevenne M, Kerff F, Guérin V, Mainil J, Thiry D, Saulmont M, Vanderplasschen A, Lafaye P, Aymé G, Bogaerts P, Dumoulin M, Galleni M.
Cawez F, et al.
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0149922. doi: 10.1128/aac.01499-22. Epub 2023 Mar 9.
Antimicrob Agents Chemother. 2023.
PMID: 36892280
Free PMC article.